New Findings from National Cancer Institute (NCI) in Carcinomas Provides New Insights (Nivolumab Plus Ipilimumab Plus Cabozantinib Triplet Combination for Patients With Previously Untreated Advanced Renal Cell Carcinoma: Results From a ...)

Prensa/medios de comunicación

Período23 dic. 2022

Cobertura de los medios

1

Cobertura de los medios

  • NombreNew Findings from National Cancer Institute (NCI) in Carcinomas Provides New Insights (Nivolumab Plus Ipilimumab Plus Cabozantinib Triplet Combination for Patients With Previously Untreated Advanced Renal Cell Carcinoma: Results From a ...)
    Nombre/canal del medio de comunicaciónImmunotherapy Daily
    País/TerritorioEstados Unidos
    Fecha23/12/22
    PersonasMauricio Burotto
Ver todos 1
Ver menos

Contenido relacionado